These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21959585)

  • 21. Transient intraneuronal A beta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice.
    Christensen DZ; Kraus SL; Flohr A; Cotel MC; Wirths O; Bayer TA
    Acta Neuropathol; 2008 Dec; 116(6):647-55. PubMed ID: 18974993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Network dysfunction in Alzheimer's disease: does synaptic scaling drive disease progression?
    Small DH
    Trends Mol Med; 2008 Mar; 14(3):103-8. PubMed ID: 18262842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
    Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synaptic plasticity in animal models of early Alzheimer's disease.
    Rowan MJ; Klyubin I; Cullen WK; Anwyl R
    Philos Trans R Soc Lond B Biol Sci; 2003 Apr; 358(1432):821-8. PubMed ID: 12740129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transgenic mouse models of Alzheimer's disease: phenotype and application.
    Higgins GA; Jacobsen H
    Behav Pharmacol; 2003 Sep; 14(5-6):419-38. PubMed ID: 14501255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age effects on the regulation of adult hippocampal neurogenesis by physical activity and environmental enrichment in the APP23 mouse model of Alzheimer disease.
    Mirochnic S; Wolf S; Staufenbiel M; Kempermann G
    Hippocampus; 2009 Oct; 19(10):1008-18. PubMed ID: 19219917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proximate Mediators of Microvascular Dysfunction at the Blood-Brain Barrier: Neuroinflammatory Pathways to Neurodegeneration.
    Festoff BW; Sajja RK; Cucullo L
    Biomed Res Int; 2017; 2017():1549194. PubMed ID: 28890893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stratification of patients is the way to go to develop neuroprotective/disease-modifying drugs for Alzheimer's disease.
    Iqbal K; Chohan MO; Grundke-Iqbal I
    J Alzheimers Dis; 2008 Oct; 15(2):339-45. PubMed ID: 18953118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuronal plasticity and degeneration.
    Schliebs R
    Int J Dev Neurosci; 2001 Jun; 19(3):229-30. PubMed ID: 11337191
    [No Abstract]   [Full Text] [Related]  

  • 31. Plasticity and Neurodegeneration: Mechanisms and Prospects for Diagnosis and Therapy of Alzheimer's Disease. Conference proceedings. Deidesheimer, 16-17 April 1994.
    Arzneimittelforschung; 1995 Mar; 45(3A):345-446. PubMed ID: 7763323
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapeutic strategies for Alzheimer disease: focus on neuronal reactivation of metabolically impaired neurons.
    Swaab DF; Dubelaar EJ; Scherder EJ; van Someren EJ; Verwer RW
    Alzheimer Dis Assoc Disord; 2003; 17 Suppl 4():S114-22. PubMed ID: 14512817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of biological sciences in understanding the genesis and a new therapeutic approach to Alzheimer's disease].
    Tęgowska E; Wosińska A
    Postepy Hig Med Dosw (Online); 2011 Feb; 65():73-92. PubMed ID: 21357996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regenerative medicine in Alzheimer's disease.
    Felsenstein KM; Candelario KM; Steindler DA; Borchelt DR
    Transl Res; 2014 Apr; 163(4):432-8. PubMed ID: 24286919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer disease brain extract stimulates branching of laminin-mediated neuronal processes.
    Kittur SD; Endo H; Adler WH; Martin GR; Markesbery WR; Kleinman HK; Weeks BS
    Alzheimer Dis Assoc Disord; 1992; 6(2):103-10. PubMed ID: 1389079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Culture and education: new frontiers in brain plasticity.
    Ansari D
    Trends Cogn Sci; 2012 Feb; 16(2):93-5. PubMed ID: 22206752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities.
    Pistollato F; Ohayon EL; Lam A; Langley GR; Novak TJ; Pamies D; Perry G; Trushina E; Williams RS; Roher AE; Hartung T; Harnad S; Barnard N; Morris MC; Lai MC; Merkley R; Chandrasekera PC
    Oncotarget; 2016 Jun; 7(26):38999-39016. PubMed ID: 27229915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review: cell cycle aberrations and neurodegeneration.
    Bonda DJ; Bajić VP; Spremo-Potparevic B; Casadesus G; Zhu X; Smith MA; Lee HG
    Neuropathol Appl Neurobiol; 2010 Apr; 36(2):157-63. PubMed ID: 20059701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe psychological stress in elderly individuals: a proposed model of neurodegeneration and its implications.
    Tsolaki M; Kounti F; Karamavrou S
    Am J Alzheimers Dis Other Demen; 2009; 24(2):85-94. PubMed ID: 19193610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer disease: NGF gene therapy activates neurons in the AD patient brain.
    Malkki H
    Nat Rev Neurol; 2015 Oct; 11(10):548. PubMed ID: 26347367
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.